
First Tracks Biotherapeutics, Inc.: updates and filings
Price
$41.64
November 20, 2026Market cap $1.7B
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
November 2026
October 2026
August 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 12, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Nov 6, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 3, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 3, 2026Results of operationsForm8-K
- Oct 29, 2026FilingFormEFFECT
- Oct 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Oct 26, 2026FilingFormS-1
- Oct 20, 2026Material agreement enteredForm8-K
- Oct 15, 2026Material agreement entered, unregistered sale of shares, Regulation FD disclosureForm8-K
- Oct 13, 2026Regulation FD disclosure, other material eventsForm8-K
- Aug 14, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Aug 14, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Aug 13, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Aug 12, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 12, 2026Results of operationsForm8-K
- Aug 6, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 28, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jun 22, 2026Material agreement enteredForm8-K
- May 14, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
- May 14, 2026Results of operationsForm8-K
- May 12, 2026FilingFormEFFECT
- May 8, 2026Correspondence with the SECFormCORRESP
- May 8, 2026FilingFormS-1
- May 6, 2026Letter from the SECFormUPLOAD
- May 1, 2026FilingFormDRS
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 12, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Nov 6, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 3, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 3, 2026 | 8-K | Results of operations | Document |
| Oct 29, 2026 | EFFECT | Filing | Document |
| Oct 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Oct 26, 2026 | S-1 | Filing | Document |
| Oct 20, 2026 | 8-K | Material agreement entered | Document |
| Oct 15, 2026 | 8-K | Material agreement entered, unregistered sale of shares, Regulation FD disclosure | Document |
| Oct 13, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Aug 14, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Aug 14, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Aug 13, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Aug 12, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 12, 2026 | 8-K | Results of operations | Document |
| Aug 6, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 28, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jun 22, 2026 | 8-K | Material agreement entered | Document |
| May 14, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
| May 14, 2026 | 8-K | Results of operations | Document |
| May 12, 2026 | EFFECT | Filing | Document |
| May 8, 2026 | CORRESP | Correspondence with the SEC | Document |
| May 8, 2026 | S-1 | Filing | Document |
| May 6, 2026 | UPLOAD | Letter from the SEC | Document |
| May 1, 2026 | DRS | Filing | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Feb 6, 2026.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.